Key populations brief
Accessed November 2017
Working Document, September 2017
Guidelines
June 2017
HIV strategic information for impact
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
Global HIV Strategic Information Working Group
For Populations At Risk For HIV
An analysis from the perspective of the health sector in Latin America and the Caribbean
Washington, D.C., 2017
WHO clinical guidelines.
For the first time, WHO has published guidelines to help (primarily) front-line healthcare providers give high-quality, compassionate, and respectful care to children and adolescents (up to age 18) who have or may have experienced sexual abuse, including sexual assault or r...ape.
more
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.11
HIV treatment
Policy brief
July 2017
WHO/HIV/2017.18
Lancet Planet Health 2017 Published Online November 6, 2017 http://dx.doi.org/10.1016/S2542-5196(17)30141-9
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more